Led the biomarker operations group in successful execution of biomarker operation activities in partnership with cross-functional teams. Accountable for implementation of biomarker strategies within the expected scope, budget and timelines.

Responsible for developing and implementing the overall companion diagnostic strategy for oncology programs from early to late stage of clinical development.Manage CDx development partnerships and serve as the single point of contact to diagnostic partner.

Developed and validated human biomarkers assays using various platforms, including ELISA, and Flow cytometry, multiplex assays, MSD to test biological samples (whole blood, serum, and plasma).Tested and analyzed samples from FIH clinical trials in validated biomarker assays.Developing ELISA based whole blood assays in human, mouse, rat, chimpanzee, and cynomolgus monkey for analyzing anti-inflammatory cytokines; small molecules; T cell co-stimulation molecules; and B cell proliferation.Screening of multiple cytokines by Multiplex technology including Cytometric Bead Array and Luminex Multiplex assay.Designed PCR primers, gene cloning, transfected mammalian cells.Allelic Discrimination using gDNAEvaluated different technology platforms.Biobank sample management.Contributed to writing clinical study protocols. scientific/technical reportsPresented and interpreted data at cross-functional project team meetings